4//SEC Filing
Loxo Oncology, Inc. 4
Accession 0001140361-17-026016
CIK 0001581720operating
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 5:24 PM ET
Size
11.8 KB
Accession
0001140361-17-026016
Insider Transaction Report
Form 4
Naider Avi Z.
Director
Transactions
- Award
Director Stock Option (right to buy)
2017-06-22+11,000→ 11,000 totalExercise: $78.58Exp: 2027-06-21→ Common Stock (11,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable in 12 equal monthly installments beginning one month after the grant date, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.
Documents
Issuer
Loxo Oncology, Inc.
CIK 0001581720
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001581720
Filing Metadata
- Form type
- 4
- Filed
- Jun 22, 8:00 PM ET
- Accepted
- Jun 23, 5:24 PM ET
- Size
- 11.8 KB